HTG Molecular Diagnostics to Announce First Quarter Financial Results and Host Conference Call on Thursday, May 10

April 27, 2018 at 4:01 PM EDT

TUCSON, Ariz., April 27, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments, reagents, and services for molecular profiling applications, today announced that it will report its financial results for the quarter ended March 31, 2018 after the market close on Thursday, May 10.  Management will also host a conference call with investors to discuss financial results and provide a corporate update at 4:30pm Eastern Time.

Conference Call & Webcast Details
Date:   Thursday, May 10
Time:   4:30pm Eastern Time
Toll Free:   866-548-4713
International:   323-794-2093
Conference ID:   5477857
Webcast:   http://public.viavid.com/index.php?id=129155

About HTG:
HTG is focused on next generation sequencing (NGS) based molecular profiling. The company’s proprietary HTG EdgeSeq technology automates complex, highly multiplexed molecular profiling from solid and liquid samples, even when limited in amount. HTG’s customers use its technology to identify biomarkers important for precision medicine, to understand the clinical relevance of these discoveries, and ultimately to identify treatment options. Our mission is to empower precision medicine at the local level.

CONTACT:
Ashley Robinson
LifeSci Advisors, LLC
617-775-5956
arr@lifesciadvisors.com

TJ Johnson
President/CEO
HTG Molecular Diagnostics
520-547-2827 x130
tjjohnson@htgmolecular.com


Primary Logo

Source: HTG Molecular Diagnostics, Inc.